425: Strive & Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. have announced a proposed business combination, with Strive filing a Form 425 communication regarding the transaction.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication was reposted on X.com by Arshia Sarkhani, Chief Marketing Officer of Strive, on September 22, 2025.
• This filing serves as a cautionary statement regarding forward-looking statements related to the proposed transaction.
• Strive intends to file a Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus, with the SEC.
• Stockholders of Semler Scientific will be asked to approve the proposed transaction.
• The document outlines various risks and uncertainties associated with the merger, including potential delays and integration challenges.

Sentiment

Score: 5

Explanation: The filing announces a significant corporate event (merger) which is generally positive, but it is primarily a cautionary statement heavily focused on outlining numerous risks and uncertainties, leading to a neutral overall sentiment.

Positives

• Anticipated strategic benefits from the proposed business combination.
• Expected financial benefits, including a positive impact on the combined company's future financial performance.
• Potential for anticipated cost savings and strategic gains from the merger.

Negatives

• Potential for dilution caused by Strive's issuance of additional Class A common stock in connection with the proposed transaction.
• Diversion of management's attention from ongoing business operations and opportunities due to the merger process.
• Potential adverse reactions from customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing could be negative.

Risks

• The merger agreement could be terminated by either Strive or Semler Scientific.
• The proposed transaction may not close as expected or at all if conditions to closing are not received or satisfied on a timely basis or at all.
• Potential legal proceedings may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized as expected or at all.
• Changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets could impact the combined company.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could affect the combined company's performance.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Actual results could differ materially from forward-looking statements due to various unpredictable factors, including unknown or unpredictable factors.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed business combination, including potential cost savings and positive impacts on the combined company's future financial performance. However, these are forward-looking statements subject to significant risks and uncertainties, and there is no assurance that actual results will align with these projections.

Management Comments

• Strive and Semler Scientific believe that their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of their existing knowledge of their business and operations.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests that at least one of the companies, or the combined entity, is involved in or plans to engage with digital asset investments, reflecting a growing trend among some corporations to incorporate cryptocurrencies into their treasury management.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of new Class A common stock.
• Shareholders of Semler Scientific will be asked to approve the transaction, impacting their ownership.
• Customers and employees of both companies may experience adverse reactions or changes to business or employee relationships due to the announcement or completion of the transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Semler Scientific stockholders will be asked to approve the proposed transaction.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury Strategy, Digital Assets